259 related articles for article (PubMed ID: 24099755)
1. Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis.
Gandaglia G; Becker A; Trinh QD; Abdollah F; Schiffmann J; Roghmann F; Tian Z; Montorsi F; Briganti A; Karakiewicz PI; Sun M
Eur J Surg Oncol; 2014 Jan; 40(1):103-12. PubMed ID: 24099755
[TBL] [Abstract][Full Text] [Related]
2. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
[TBL] [Abstract][Full Text] [Related]
3. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
4. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy.
Mistretta FA; Mazzone E; Palumbo C; Knipper S; Tian Z; Nazzani S; Lattouf JB; Musi G; Perrotte P; Montanari E; Shariat SF; Montorsi F; Saad F; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2019 Aug; 17(4):e793-e801. PubMed ID: 31182339
[TBL] [Abstract][Full Text] [Related]
6. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors.
Chamie K; Kurzrock EA; Evans CP; Litwin MS; Koppie TM; Wootton-Gorges SL; Boone JM; Lara PN; Devere White RW
Cancer; 2011 Sep; 117(18):4219-30. PubMed ID: 21412759
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: a population-based analysis.
Ahmed KA; Wilder RB
Cancer Epidemiol; 2014 Apr; 38(2):124-8. PubMed ID: 24613492
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors.
Palumbo C; Mistretta FA; Mazzone E; Knipper S; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lattouf JB; Karakiewicz PI
Clin Genitourin Cancer; 2019 Oct; 17(5):e1026-e1035. PubMed ID: 31378580
[TBL] [Abstract][Full Text] [Related]
9. Marital status independently predicts testis cancer survival--an analysis of the SEER database.
Abern MR; Dude AM; Coogan CL
Urol Oncol; 2012; 30(4):487-93. PubMed ID: 20870430
[TBL] [Abstract][Full Text] [Related]
10. The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis.
Gandaglia G; Karakiewicz PI; Abdollah F; Becker A; Roghmann F; Sammon JD; Kim SP; Perrotte P; Briganti A; Montorsi F; Trinh QD; Sun M
Eur J Surg Oncol; 2014 Dec; 40(12):1706-15. PubMed ID: 24915856
[TBL] [Abstract][Full Text] [Related]
11. Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients.
Fosså SD; Cvancarova M; Chen L; Allan AL; Oldenburg J; Peterson DR; Travis LB
J Clin Oncol; 2011 Mar; 29(8):963-70. PubMed ID: 21300926
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Prognostic Factors of Racial Disparities in Testicular Germ Cell Tumor Survival in the United States (1992-2015).
Wu J; Ji YB; Tang BW; Brown M; Wang BH; Du CL; Du JS; Wang XM; Cai LJ; Wu GY; Zhou Y
Biomed Environ Sci; 2021 Feb; 34(2):152-162. PubMed ID: 33685574
[TBL] [Abstract][Full Text] [Related]
13. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
14. Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls.
Morra S; Piccinelli ML; Cano Garcia C; Tappero S; Barletta F; Incesu RB; Scheipner L; Baudo A; Tian Z; Saad F; Mirone V; Califano G; Colla' Ruvolo C; Shariat SF; de Cobelli O; Musi G; Chun FKH; Terrone C; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
Int Urol Nephrol; 2023 Dec; 55(12):3119-3128. PubMed ID: 37640983
[TBL] [Abstract][Full Text] [Related]
15. A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Tian Z; Shariat SF; Widmer H; Zorn K; Menon M; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2011 Dec; 60(6):1152-9. PubMed ID: 21868147
[TBL] [Abstract][Full Text] [Related]
16. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
[TBL] [Abstract][Full Text] [Related]
17. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival.
Patel HD; Srivastava A; Alam R; Joice GA; Schwen ZR; Semerjian A; Allaf ME; Pierorazio PM
Urol Oncol; 2017 Oct; 35(10):606.e1-606.e7. PubMed ID: 28712791
[TBL] [Abstract][Full Text] [Related]
20. Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis.
Jones G; Arthurs B; Kaya H; Macdonald K; Qin R; Fairbanks RK; Lamoreaux WT; Jawed I; Tward JD; Martincic D; Shivnani AT; Lee CM
Am J Clin Oncol; 2013 Oct; 36(5):500-4. PubMed ID: 22781383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
